5 results match your criteria: "Oslo University Hospital The Radium Hospital[Affiliation]"
Transpl Int
November 2024
Department of Immunology, Oslo University Hospital, Oslo, Norway.
Normothermic machine perfusion (NMP) is a clinical strategy to reduce renal ischemia-reperfusion injury (IRI). Optimal NMP should restore metabolism and minimize IRI induced inflammatory responses. Microdialysis was used to evaluate renal metabolism.
View Article and Find Full Text PDFScand J Surg
March 2024
Department of Gastroenterological Surgery, Oslo University Hospital, The Radium Hospital, Oslo, Norway.
Aim: Rectal cancers requiring beyond total mesorectal excision (bTME) are traditionally operated using an open approach, but the use of minimally invasive robot-assisted procedures is increasing. Introduction of minimal invasive surgery for complex cancer cases could be associated with compromised surgical margins or increased complication rates. Therefore, reporting results both clinical and oncological in large series is important.
View Article and Find Full Text PDFAnn Surg Oncol
September 2021
Department of Gastroenterological Surgery, Oslo University Hospital The Radium Hospital, Oslo, Norway.
Background: Despite extensive cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC), most patients with resectable peritoneal metastases from colorectal cancer experience disease relapse. MOC31PE immunotoxin is being explored as a novel treatment option for these patients. MOC31PE targets the cancer-associated epithelial cell adhesion molecule, and kills cancer cells by distinct mechanisms, simultaneously causing immune activation by induction of immunogenic cell death (ICD).
View Article and Find Full Text PDFInt J Radiat Oncol Biol Phys
April 2020
Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.
Purpose: The aim of this study was to investigate the influence of brachytherapy technique and applicator type on target dose, isodose surface volumes, and organ-at-risk (OAR) dose.
Methods And Materials: Nine hundred two patients treated with tandem/ovoids (T&O) (n = 299) and tandem/ring (T&R) (n = 603) applicators from 16 EMBRACE centers were analyzed. Patients received external beam radiation therapy and magnetic resonance imaging guided brachytherapy with dose prescription according to departmental practice.